Sponsor
Scott Fitzgerald
Representative · R-WI
Representative · R-WI
The bill gives law enforcement and prosecutors stronger, faster tools to target and deter fentanyl‑related trafficking (potentially reducing overdoses), at the cost of greater regulatory burdens on researchers, heightened risk of overcriminalization and due‑process disparities, and possible long‑term erosion of enforcement effectiveness.
Members of the public may see fewer overdose deaths because prosecutors and enforcers can more quickly target and deter distribution of new fentanyl-related substances.
Law‑enforcement and border agencies can more quickly classify, seize, and penalize shipments and inventories of novel fentanyl-related compounds, simplifying interdiction at the border and in domestic trafficking cases.
Federal prosecutors can more easily charge sellers and traffickers of fentanyl-related substances without needing complex analogue proof, streamlining prosecutions of suppliers.
Researchers, legitimate manufacturers, and patients could face slowed research and development and greater regulatory burdens (including Schedule I restrictions), delaying access to new opioid therapies or scientific work.
Defendants may face harsher penalties and increased prosecutions (including for trace amounts or related isomers) without individualized analogue proof, raising overcriminalization and due‑process risks.
Expanding prosecutorial discretion and lowering scientific proof requirements could lead to uneven application and higher incarceration rates that disproportionately affect racial and ethnic minorities.
Based on analysis of 4 sections of legislative text.
Creates a broad Schedule I class for fentanyl-related substances defined by chemical structure and treats them as analogues for enhanced criminal and import/export penalties.
Official title: To amend the Controlled Substances Act to list fentanyl-related substances as schedule I controlled substances.
Introduced February 6, 2025 by Scott Fitzgerald · Last progress February 6, 2025
The bill broadly adds a class-based Schedule I listing for "fentanyl-related substances," defining them by structural changes to fentanyl rather than by naming individual compounds, and treats any such substance as an analogue for purposes of enhanced criminal and import/export penalties. It makes these changes effective one day after enactment, expanding the criminal scope and simplifying prosecution for possession, distribution, and importation of fentanyl analogues.